Follow The Filings

NOV

Earnings company data as of 3:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 0.24 — —
Rev — — —

Insider trades

Open-market buys and sales by NOV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NOV insider trades
  • $1M bought by 1 insider
  • $4.6M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. David D Harrison Director
    Sale
    $184K 9,594 shares at $19.21 7% of stake
    Traded Jul 31 Filed Jul 31
  2. Craig L. Weinstock Sr. VP. & Gen. Counsel
    Sale
    $1.4M 70,000 shares at $20.08 22% of stake
    Traded Feb 23 Filed Feb 24
  3. Joseph W Rovig President - Energy Equipment
    Sale
    $3M 151,086 shares at $20.17 36% of stake
    Traded Feb 23 Filed Feb 24
  4. Christian S Kendall Director
    Buy
    $1M 70,000 shares at $14.46 +439% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 24 share withholdings for taxes, 17 stock grants, 4 sales back to the company, and 4 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 5.02

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.